Cardiac Device Specialists are healthcare professionals who focus on the management, implantation, and troubleshooting of devices that support or regulate heart function. These devices include pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and implantable loop recorders. Their expertise is essential for patients with arrhythmias, heart failure, or other cardiac conditions that impair the heart’s electrical system. By carefully selecting and programming these devices, cardiac device specialists help restore normal heart rhythm, prevent sudden cardiac events, and improve overall cardiac performance.
Working closely with electrophysiologists, cardiologists, and surgeons, cardiac device specialists provide comprehensive care that includes patient education, follow-up monitoring, and device maintenance. Advances in technology have led to smaller, more sophisticated devices with longer battery life and remote monitoring capabilities, making the role of these specialists even more critical. They are also involved in clinical research to evaluate new device technologies and optimize patient outcomes. Through their skill and dedication, cardiac device specialists enhance quality of life, reduce hospitalizations, and help patients safely manage complex heart conditions over the long term. Their ongoing commitment to innovation ensures patients receive the most effective and up-to-date therapies available. They also play a vital role in training the next generation of clinicians in the safe use and management of cardiac devices.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India